Hebei Changshan Biochem Pharma (300255) — Financial Flexibility Index
Hebei Changshan Biochem Pharma (300255) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of CN¥-6.39 Million (operating CF CN¥-30.86 Million minus capex CN¥24.47 Million) represents 0% of total liabilities (CN¥3.18 Billion). Check 300255 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hebei Changshan Biochem Pharma Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Hebei Changshan Biochem Pharma across 17 annual periods. See working capital to net assets of Hebei Changshan Biochem Pharma to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Hebei Changshan Biochem Pharma (2008–2024)
Year-by-year free cash flow to debt coverage for Hebei Changshan Biochem Pharma. For the full company profile including market capitalisation, see Hebei Changshan Biochem Pharma market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.10x | CN¥295.81 Million | CN¥56.22 Million | CN¥2.99 Billion | ▲ +1.4% |
| 2023 | 0.10x | CN¥273.05 Million | CN¥33.73 Million | CN¥2.80 Billion | ▼ -33.0% |
| 2022 | 0.15x | CN¥434.35 Million | CN¥3.13 Million | CN¥2.98 Billion | ▼ -0.8% |
| 2021 | 0.15x | CN¥310.95 Million | CN¥2.87 Million | CN¥2.12 Billion | ▲ +1458.4% |
| 2020 | 0.01x | CN¥16.20 Million | CN¥-183.58 Million | CN¥1.72 Billion | ▼ -89.1% |
| 2019 | 0.09x | CN¥105.28 Million | CN¥-58.13 Million | CN¥1.22 Billion | ▼ -78.4% |
| 2018 | 0.40x | CN¥527.65 Million | CN¥292.81 Million | CN¥1.32 Billion | ▲ +36.3% |
| 2017 | 0.29x | CN¥320.58 Million | CN¥162.28 Million | CN¥1.09 Billion | ▼ -8.1% |
| 2016 | 0.32x | CN¥268.48 Million | CN¥171.96 Million | CN¥842.59 Million | ▲ +411.0% |
| 2015 | 0.06x | CN¥47.20 Million | CN¥-38.14 Million | CN¥757.07 Million | ▼ -41.8% |
| 2014 | 0.11x | CN¥66.24 Million | CN¥-84.97 Million | CN¥617.87 Million | ▼ -84.7% |
| 2013 | 0.70x | CN¥251.96 Million | CN¥-15.24 Million | CN¥359.78 Million | ▲ +274.5% |
| 2012 | 0.19x | CN¥54.75 Million | CN¥-70.62 Million | CN¥292.77 Million | ▼ -21.7% |
| 2011 | 0.24x | CN¥47.47 Million | CN¥17.04 Million | CN¥198.78 Million | ▼ -24.5% |
| 2010 | 0.32x | CN¥66.80 Million | CN¥29.25 Million | CN¥211.25 Million | ▼ -29.8% |
| 2009 | 0.45x | CN¥48.26 Million | CN¥24.21 Million | CN¥107.15 Million | ▲ +259.9% |
| 2008 | -0.28x | CN¥-29.05 Million | CN¥-30.83 Million | CN¥103.16 Million | — |